Literature DB >> 20173379

Effect of dexmedetomidine on testicular torsion/detorsion damage in rats.

Volkan Hanci1, Bülent Erol, Sibel Bektaş, Görkem Mungan, Serhan Yurtlu, Hüsnü Tokgöz, Murat Can, Işil Ozkoçak Turan.   

Abstract

BACKGROUND AND
OBJECTIVE: We assessed the antioxidant activity of dexmedetomidine (DEX) during an ischemic period in a rat model of testicular torsion/detorsion (T/DT) by using biochemical and histopathological methods.
METHODS: Wistar Albino male rats weighing 250-300 g were divided into three groups: sham (group S, n = 7); torsion/detorsion (group T/DT, n = 7), and DEX treatment (group DEX, n = 7). In the T/DT group, right testes were rotated 720 degrees for 1 h. Group S served for normal basal values. Rats in group T/DT were operated to make T/DT, this group served as a control group. Group DEX received intraperitoneal DEX 10 microg . kg(-1) after the 30-min torsion period. For measurement of total antioxidant enzyme activities and malondialdehyde (MDA) levels, testes of 7 animals in each group were excised after 4 h of reperfusion. Germ cell apoptosis was evaluated using the apoptosis protease-activating factor 1 (APAF-1) antibody in all groups and also on the expressions of endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) were assessed within the bilateral testes.
RESULTS: Mean MDA levels in group T/DT were significantly higher than in groups S and DEX (p < 0.05). There were also significant decreases in mean total antioxidant activities in group T/DT when compared to groups S and DEX (p < 0.05). These values were significantly higher in group DEX than group T/DT. Germ cell apoptosis, eNOS and iNOS levels were significantly higher in group T/DT when compared to groups S and DEX (p < 0.05).
CONCLUSIONS: DEX treatment has potential biochemical and histopathological benefits by preventing ischemia/reperfusion-related cellular damage in an experimental testicular torsion model. Preference of DEX for anesthesia during the detorsion procedure may attenuate ischemia-reperfusion injury. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20173379     DOI: 10.1159/000273476

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  17 in total

1.  Naloxone pretreatment prevents kidney injury after liver ischemia reperfusion injury.

Authors:  Mohammad Ashrafzadeh Takhtfooladi; Mehran Shahzamani; Ahmad Asghari; Aris Fakouri
Journal:  Int Urol Nephrol       Date:  2016-04-07       Impact factor: 2.370

2.  Medical perspective in testicular ischemia-reperfusion injury.

Authors:  Salvatore Arena; Roberta Iacona; Pietro Antonuccio; Tiziana Russo; Vincenzo Salvo; Eloisa Gitto; Pietro Impellizzeri; Carmelo Romeo
Journal:  Exp Ther Med       Date:  2017-03-30       Impact factor: 2.447

3.  Protective effects of dexmedetomidine on intestinal ischemia-reperfusion injury.

Authors:  Yong Sun; Qiang Gao; Nan Wu; Sheng-DE Li; Jing-Xin Yao; Wen-Jie Fan
Journal:  Exp Ther Med       Date:  2015-06-10       Impact factor: 2.447

4.  Dexmedetomidine alleviates the spinal cord ischemia-reperfusion injury through blocking mast cell degranulation.

Authors:  Jun Ma; Xiao-Long Zhang; Cheng-Yu Wang; Zhi Lin; Jie-Ru Tao; Hua-Cheng Liu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  Testicular Torsion and Spermatogenesis.

Authors:  Omar Al Hussein Alawamlh; Ryan Flannigan; Russell Hayden; Marc Goldstein; Philip S Li; Richard K Lee
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Mechanisms of testicular torsion and potential protective agents.

Authors:  Ersagun Karaguzel; Mustafa Kadihasanoglu; Omer Kutlu
Journal:  Nat Rev Urol       Date:  2014-06-17       Impact factor: 14.432

Review 7.  Contemporary review of testicular torsion: new concepts, emerging technologies and potential therapeutics.

Authors:  Daniel G DaJusta; Candace F Granberg; Carlos Villanueva; Linda A Baker
Journal:  J Pediatr Urol       Date:  2012-10-06       Impact factor: 1.830

8.  Dexmedetomidine protects against lipid peroxidation and erythrocyte deformability alterations in experimental hepatic ischemia reperfusion injury.

Authors:  Mustafa Arslan; Faruk Metin Çomu; Ayşegül Küçük; Levent Oztürk; Faik Yaylak
Journal:  Libyan J Med       Date:  2012-05-24       Impact factor: 1.657

9.  The effects of dexmedetomidine on secondary acute lung and kidney injuries in the rat model of intra-abdominal sepsis.

Authors:  Uğur Koca; Çimen Gülben Olguner; Bekir Uğur Ergür; Emel Altekin; Aydın Taşdöğen; Seden Duru; Pelin Girgin; Kerim Gündüz; Serap Cilaker Mıcılı; Seda Güzeldağ; Muhammed Akkuş
Journal:  ScientificWorldJournal       Date:  2013-02-13

10.  Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation.

Authors:  Yanna Si; Hongguang Bao; Liu Han; Hongwei Shi; Yuan Zhang; Li Xu; Chenhui Liu; Jinsong Wang; Xiaobing Yang; Akbar Vohra; Daqing Ma
Journal:  J Transl Med       Date:  2013-06-09       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.